RE:RE:RE:RE:RE:RE:Wtf,,huummmm,,, I dont think anyone here is losing their minds over the PP,,,they are expressing opinions,,and when you are a long time RVX investor the story just dont seem to change when one looks back. What makes things offensive is the lack of info from DMcC,,he could have noted in his video of late that a PP would be looked at before year end and the reasoning for such when a deal is so close at hand in theory. Seems to me the only thing this does not change would be the price for a buy out for BP,,,,it certainly adds a nice tad of dilution for all present shareholders.
On a side note,,I think it is very obvious to the market that we are not looking at the best business model within the walls of RVX. There would seem to be a few possibilites to bring this science to patients in a more timely fashion and have the synergy to strengthen our balance sheet. But nope,,,not in the cards,,,,as these years pass. There also has to be multiply possiblities around agreements to fulfill moral obligations to best bring epigentics into the public realm. I think the team and its major investors are focusing on themselves. It can be assured they know when PPs are coming,,,,,,however the retail guy ro gal is excluded......even the June/21 warrants are in danger of expiring worthless,,,,,,only 9 months away,,,and you can rest assured the BoM2 will still be in the planning stage at that time,,,,,dead money here at least out to H2..the market sees no urgency.... jmo